Advertisement
Screener

DataMeds AI, Inc. (MEDS) Graph

MEDS Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $1.78M; Cost of revenue $1.60M; Operating expenses $7.53M; Net income -$18.36M.
  • 2026-03-31: Revenue $1.56M; Cost of revenue $1.39M; Operating expenses $6.19M; Net income -$7.74M.
  • 2025-12-31: Revenue $1.67M*; Cost of revenue $9.53M*; Operating expenses $17.50M*; Net income -$27.85M*.
  • 2025-09-30: Revenue $3.01M; Cost of revenue $2.78M; Operating expenses $31.78M; Net income -$34.32M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

MEDS revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Pharmacy Retail Sales$1.59MThird PartyLogistics Services$122.73KProduct$66.76KRevenue$1.78MCost of revenue$1.60MGross profit$182.20KOperating expenses$7.53MOperating income-$7.35MPre-tax income-$18.36MNet income-$18.36M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueOperating expensesNet income
2026-06-30$1.78M$1.60M$7.53M-$18.36M
2026-03-31$1.56M$1.39M$6.19M-$7.74M
2025-12-31$1.67M*$9.53M*$17.50M*-$27.85M*
2025-09-30$3.01M$2.78M$31.78M-$34.32M
2025-06-30$7.79M$7.29M$6.01M-$6.67M
2025-03-31$10.86M$10.17M$32.04M-$32.43M
2024-09-30$5.67M$5.15M$2.27M-$1.87M
2024-06-30$44.54K$47.15K$570.41K-$574.33K
2024-03-31(m)(m)$79.76K-$83.12K

Revenue and expense 6 month

Period endRevenueCost of revenueOperating expensesNet income
2026-06-30$3.34M$2.99M$13.71M-$26.11M
2025-06-30$18.65M$17.46M$38.05M-$39.10M
2024-06-30$44.54K$47.15K$650.17K-$657.45K

Revenue and expense 9 month

Period endRevenueCost of revenueOperating expensesNet income
2025-09-30$21.67M$20.24M$69.83M-$73.42M
2024-09-30$5.72M$5.20M$2.92M-$2.52M

Revenue and expense 12 month

Period endRevenueCost of revenueOperating expensesNet income
2025-12-31$23.34M$29.76M$87.32M-$101.27M
2024-12-31$18.13M$16.36M$7.91M-$6.86M
2023-12-31(m)(m)$2.88M-$2.90M

Similar stocks

Stock NameCountryMarket CapPE Ratio
HWH International Inc. (HWH)United States$0.021B-4.08
Cosmos Health Inc. (COSM)Greece$0.038B-0.60
NU SKIN ENTERPRISES, INC. (NUS)United States$0.225B-1.18
HERBALIFE LTD. (HLF)$1.281B8.39
CARDINAL HEALTH INC (CAH)United States$51.753B29.38
Cencora, Inc. (COR)United States$59.130B20.57
MCKESSON CORP (MCK)United States$101.317B19.78